Share this post on:

Earch was funded by a April 2004 and No. 673 approved on 7 April 2008). (protocol code No. 295 approved on 23grant in the Fukushima Society for the Promotion of Informed Consent Statement: Written informed consent was obtained from all subjects involved in Institutional Assessment Board Statement: The study was conducted in line with the guidelines from the theDeclaration of Helsinki, and authorized by the Ethics Committee of Fukushima Healthcare University study. Data Availability Statement: The data presented in this study could possibly be available on request from the Informed Consent Statement: Written informed consent was obtained from all subjects involved was corresponding author. The information will not be publicly accessible since the Vatiquinone Data Sheet underlying information in obtained the study. from the collaboration together with the local government and includes sensitive information and facts on people Data Availability Statement: The data presented in sharing could data openly is prohibited such as gender, age and self-reported data, andthis study these be readily available on request from by the local the corresponding author. The information are University Ethics since the underlying information was obgovernment and Fukushima Medicalnot publicly out there Committee.tained in the collaboration with the neighborhood government and includes sensitive information and facts on individuals like The authors self-reported information, and sharing these Takeyachi, Takahashi, Acknowledgments:gender, age andthank A. Onda, K. Yamauchi, Y. information openly isIprohibited H. Tachiby and B. government and Fukushima Medical information collection inside the initial hara, the localTakayama for participating in theUniversity Ethics Committee. evaluation. The authors also thank 5 public health authors thank A.Fujita N,Yamauchi, Y. Takeyachi, I Takahashi, H. Kanno S, for their Acknowledgments: The nurses, Mses. Onda, K. Hoshi N, Hoshi M, Imada N, and Tachihara, in B. Takayama for participating the initial analysis and six-year follow-up. supportand carrying out this study at within the data collection within the initial analysis. The authors also thank five public health nurses, Mses. Fujita N, Hoshi N, Hoshi M, Imada N, and Kanno S, for their (protocol code No.295 authorized on April 23, 2004 and No. 673 approved on April 7, 2008).Conflicts of carrying out thisauthors declare no conflict of interest. support in Interest: The study at the initial analysis and six-year follow-up.Appendix AAppendixConflicts of Interest: The authors declare no conflict of interest.Medicina 2021, 57,13 ofmedicinaArticleComparison and Overall performance Validation of Calculated and Established Anaerobic Lactate Thresholds in RunningSanghyeon Ji 1,2 , Aldo Sommer 1,three , Wilhelm Bloch 1,3 and Patrick Wahl four, The TNP-470 supplier German Analysis Centre of Elite Sport, German Sport University Cologne, 50933 Cologne, Germany; [email protected] (S.J.); [email protected] (A.S.); [email protected] (W.B.) Department of Sports Medicine and Physical exercise Physiology, Institute of Sport Sciences, Goethe University Frankfurt, 60487 Frankfurt, Germany Division of Molecular and Cellular Sport Medicine, Institute of Cardiology and Sports Medicine, German Sport University Cologne, 50933 Cologne, Germany Institute of Interdisciplinary Physical exercise Science and Sports Medicine, Healthcare College Hamburg, 20457 Hamburg, Germany Correspondence: [email protected]; Tel.: 49-40-361-226-Citation: Ji, S.; Sommer, A.; Bloch, W.; Wahl, P. Comparison and Functionality Validation of Calculated and Established Anaerobic Lacta.

Share this post on:

Author: DNA_ Alkylatingdna